Evidence map›Paper›PMID 39541997›Full record

ArticleThe lancet. Diabetes & endocrinology2024

Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium.

Dianna J Magliano, Lei Chen, Jedidiah I Morton, Agus Salim, Bendix Carstensen, Edward W Gregg, Meda E Pavkov, Martti Arffman, Helen M Colhoun, Kyoung Hwa Ha and 10 more

Abstract read
In one paragraph

Article in The lancet. Diabetes & endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Cardiovascular disease risk factors in young people with diabetes mellitus.Cardiovascular diabetology. Endocrinology reports · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Dianna J MaglianoDepartment of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: dianna.magliano@baker.edu.au.
Lei ChenDepartment of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Jedidiah I MortonDepartment of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia.
Agus SalimDepartment of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; School of Mathematics and Statistics, The University of Melbourne, Melbourne, VIC, Australia.
Bendix CarstensenClinical Epidemiology, Steno Diabetes Centre Copenhagen, Herlev, Denmark.
Edward W GreggSchool of Population Health, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Meda E PavkovDivision of Diabetes Translation, Centers for Diseases Control and Prevention, Atlanta, GA, USA.
Martti ArffmanDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Helen M ColhounInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Kyoung Hwa HaDepartment of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
Tomoaki ImamuraDepartment of Public Health, Health Management and Policy, Nara Medical University, Nara, Japan.
György Jermendy3rd Medical Department, Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
Dae Jung KimDepartment of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
Zoltán Kiss2nd Department of Medicine and Nephrological Center, Medical Faculty, University of Pécs, Pécs, Hungary.
Didac MauricioCIBER of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain; Institut Català de la Salut, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona, Spain; Department of Endocrinology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
Stuart J McGurnaghanInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Yuichi NishiokaDepartment of Public Health, Health Management and Policy, Nara Medical University, Nara, Japan.
Sarah H WildUsher Institute, University of Edinburgh, Edinburgh, UK.
Klas WinellDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Unit of Public Health, University of Turku, 20014 University of Turku, Finland.
Jonathan E ShawDepartment of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; School of Life Sciences, La Trobe University, Melbourne, VIC, Australia.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundPopulation-based incidence data on young-adult-onset type 1 diabetes and type 2 diabetes are limited. We aimed to examine secular trends in the incidence of diagnosed type 1 diabetes and type 2 diabetes with an age of onset between 15 and 39 years.

methodsIn this multicountry aggregate data analysis, we assembled eight administrative datasets from high-income jurisdictions and countries (Australia, Denmark, Finland, Hungary, Japan, Scotland, South Korea, and Spain [Catalonia]) that had appropriate data available from an international diabetes consortium (GLOBODIAB) describing incidence by diabetes type among people aged 15-39 years from 2000 to 2020. We modelled type 1 diabetes and type 2 diabetes incidence rates using Poisson regression including age and calendar time by sex.

findingsDuring the years 2000-20, there were 349 591 incident diabetes (both types) cases from 346 million person-years of follow-up among people aged 15-39 years. Over time, there was no statistically significant change in the incidence of type 1 diabetes in Hungary and Japan. The incidence of type 1 diabetes significantly increased in Australia, Denmark, Finland, Scotland, South Korea, and Spain, with annual changes ranging from 0·5% to 6·0%. The incidence of type 2 diabetes significantly increased in four of eight jurisdictions (Denmark, Finland, Japan, and South Korea), with annual increases from 2·0% to 8·5%. The magnitude of increase in incidence of type 2 diabetes was greater in Asian than non-Asian jurisdictions. There was no statistically significant change in type 2 diabetes incidence in Australia and Hungary. The incidence of type 2 diabetes significantly decreased in Scotland and Spain, with annual changes of -0·7% and -1·5%, respectively.

interpretationThere is variability in the trajectory of the incidence of young-adult-onset type 2 diabetes among high-income countries or jurisdictions, with a greater evidence of increase in Asian than non-Asian countries. Evolving trends in the incidence of type 1 and type 2 diabetes in young adults call for the ongoing surveillance of diabetes incidence and a greater research focus on this population.

fundingUS Centers for Disease Control and Prevention, Diabetes Australia Research Programme, and Victoria State Government Operational Infrastructure Support Programme.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2AdolescentAdultAge of OnsetAustraliaFemaleHumansIncidenceMaleYoung Adult

Identifiers

PMID39541997
PMCPMC11812581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.